{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:15:28Z","timestamp":1761714928888,"version":"build-2065373602"},"reference-count":96,"publisher":"CSIRO Publishing","issue":"8","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":2218,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,10]]},"abstract":"<jats:p>It is known that androgen excess induces changes in fetal programming that affect several physiological pathways. Peroxisome proliferator-activated receptors (PPARs) a, d and ? are key mediators of female reproductive functions, in particular in uterine tissues. Thus, we aimed to study the effect of prenatal hyperandrogenisation on the uterine PPAR system. Rats were treated with 2 mg testosterone from Day 16 to 19 of pregnancy. Female offspring (PH group) were followed until 90 days of life, when they were killed. The PH group exhibited an anovulatory phenotype. We quantified uterine mRNA levels of PPARa (Ppara), PPARd (Ppard), PPAR? (Pparg), their regulators peroxisome proliferator-activated receptor gamma coactivator 1-alpha (Ppargc1a) and nuclear receptor co-repressor 1 (Ncor1) and cyclo-oxygenase (COX)-2 (Ptgs2), and assessed the lipid peroxidation (LP) index and levels of glutathione (GSH) and prostaglandin (PG) E2. The PH group showed decreased levels of all uterine PPAR isoforms compared with the control group. In addition, PGE2 and Ptgs2 levels were increased in the PH group, which led to a uterine proinflammatory environment, as was LP, which led to a pro-oxidant status that GSH was not able to compensate for. These results suggest that prenatal exposure to androgen excess has a fetal programming effect that affects the gene expression of PPAR isoforms, and creates a misbalanced oxidant\u2013antioxidant state and a proinflammatory status.<\/jats:p>","DOI":"10.1071\/rd18432","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T22:00:21Z","timestamp":1556661621000},"page":"1401-1409","source":"Crossref","is-referenced-by-count":4,"title":["Prenatal androgen excess alters the uterine peroxisome proliferator-activated receptor (PPAR) system"],"prefix":"10.1071","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4323-167X","authenticated-orcid":true,"given":"Silvana R.","family":"Ferreira","sequence":"first","affiliation":[{"name":"ALaboratorio de Fisio-Patolog\u00eda Ov\u00e1rica, Centro de Estudios Farmacol\u00f3gicos y Bot\u00e1nicos, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, C1121 ABG, Buenos Aires, Argentina."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro M.","family":"V\u00e9lez","sequence":"additional","affiliation":[{"name":"ALaboratorio de Fisio-Patolog\u00eda Ov\u00e1rica, Centro de Estudios Farmacol\u00f3gicos y Bot\u00e1nicos, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, C1121 ABG, Buenos Aires, Argentina."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"F. Heber","sequence":"additional","affiliation":[{"name":"ALaboratorio de Fisio-Patolog\u00eda Ov\u00e1rica, Centro de Estudios Farmacol\u00f3gicos y Bot\u00e1nicos, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, C1121 ABG, Buenos Aires, Argentina."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle A.","family":"Abruzzese","sequence":"additional","affiliation":[{"name":"ALaboratorio de Fisio-Patolog\u00eda Ov\u00e1rica, Centro de Estudios Farmacol\u00f3gicos y Bot\u00e1nicos, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, C1121 ABG, Buenos Aires, Argentina."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia B.","family":"Motta","sequence":"additional","affiliation":[{"name":"ALaboratorio de Fisio-Patolog\u00eda Ov\u00e1rica, Centro de Estudios Farmacol\u00f3gicos y Bot\u00e1nicos, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, C1121 ABG, Buenos Aires, Argentina."},{"name":"BCorresponding author. Email: aliciabmotta@yahoo.com.ar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"2025102819544982200_R1","doi-asserted-by":"publisher","first-page":"E741","DOI":"10.1152\/AJPENDO.00058.2010","article-title":"Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring.","volume":"299","author":"Abbott","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2025102819544982200_R2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/JOE-15-0471","article-title":"Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism.","volume":"230","author":"Abruzzese","year":"2016","journal-title":"J. Endocrinol."},{"key":"2025102819544982200_R3","doi-asserted-by":"publisher","DOI":"10.1111\/JNE.12632","article-title":"Developmental programming of the female neuroendocrine system by steroids.","volume":"30","author":"Abruzzese","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"2025102819544982200_R4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.7556\/JAOA.1999.99.11.S7","article-title":"COX-1 and COX-2 in health and disease.","volume":"99","author":"Adelizzi","year":"1999","journal-title":"J. Am. Osteopath. Assoc."},{"key":"2025102819544982200_R5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1477-7827-3-28","article-title":"Role of oxidative stress in female reproduction.","volume":"3","author":"Agarwal","year":"2005","journal-title":"Reprod. Biol. Endocrinol."},{"key":"2025102819544982200_R6","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0037658","article-title":"Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure.","volume":"7","author":"Amalfi","year":"2012","journal-title":"PLoS One"},{"key":"2025102819544982200_R7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1248\/BPB.B17-00371","article-title":"A PPAR pan agonist, MHY2013 alleviates age-related hepatic lipid accumulation by promoting fatty acid oxidation and suppressing inflammation.","volume":"41","author":"An","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"2025102819544982200_R8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/J.METABOL.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): long-term metabolic consequences.","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"2025102819544982200_R9","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1093\/HUMREP\/DEL183","article-title":"Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome.","volume":"21","author":"Avellaira","year":"2006","journal-title":"Hum. Reprod."},{"key":"2025102819544982200_R10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/J.1479-828X.2007.00744.X","article-title":"Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model.","volume":"47","author":"Aytan","year":"2007","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"2025102819544982200_R11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/J.JSBMB.2008.03.031","article-title":"In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.","volume":"110","author":"Bacallao","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2025102819544982200_R12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/HUMUPD\/7.6.522","article-title":"Polycystic ovary syndrome and cancer.","volume":"7","author":"Balen","year":"2001","journal-title":"Hum. Reprod. Update"},{"key":"2025102819544982200_R13","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/142082","article-title":"PPAR signaling in placental development and function.","volume":"2008","author":"Barak","year":"2008","journal-title":"PPAR Res."},{"key":"2025102819544982200_R14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/S00423-006-0073-1","article-title":"Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair.","volume":"391","author":"Bartsch","year":"2006","journal-title":"Langenbecks Arch. Surg."},{"key":"2025102819544982200_R15","first-page":"559","article-title":"The quantitative expression of peroxisome proliferator activated receptor (PPAR) genes in porcine endometrium through the estrous cycle and early pregnancy.","volume":"62","author":"Bogacka","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"2025102819544982200_R16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5603\/FHC.A2015.0023","article-title":"Peroxisome proliferator-activated receptors in the regulation of female reproductive functions.","volume":"53","author":"Bogacka","year":"2015","journal-title":"Folia Histochem. Cytobiol."},{"key":"2025102819544982200_R17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1530\/REP.1.00799","article-title":"Developmental regulation of prostacyclin synthase and prostacyclin receptors in the ovine uterus and conceptus during the peri-implantation period.","volume":"131","author":"Cammas","year":"2006","journal-title":"Reproduction"},{"key":"2025102819544982200_R18","doi-asserted-by":"publisher","DOI":"10.1621\/NRS.04003","article-title":"Nuclear receptor corepressors and PPAR?.","volume":"4","author":"Cohen","year":"2006","journal-title":"Nucl. Recept. Signal."},{"key":"2025102819544982200_R19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/J.THERIOGENOLOGY.2008.05.048","article-title":"Dietary n-3 polyunsaturated fatty acids alter the expression of genes involved in prostaglandin biosynthesis in the bovine uterus.","volume":"70","author":"Coyne","year":"2008","journal-title":"Theriogenology"},{"key":"2025102819544982200_R20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.EJPHAR.2003.10.056","article-title":"Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.","volume":"483","author":"Cuzzocrea","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"2025102819544982200_R21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/J.JSGI.2005.10.002","article-title":"Effect of peroxisome proliferator-activated receptor-? agonist rosiglitazone on the induction of endometriosis in an experimental rat model.","volume":"13","author":"Demirturk","year":"2006","journal-title":"J. Soc. Gynecol. Investig."},{"key":"2025102819544982200_R22","doi-asserted-by":"publisher","first-page":"E262","DOI":"10.1152\/AJPENDO.90208.2008","article-title":"Transient prenatal androgen exposure produces metabolic syndrome in adult female rats.","volume":"295","author":"Demissie","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2025102819544982200_R23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1196\/ANNALS.1367.006","article-title":"Stress in women: metabolic syndrome and polycystic ovary syndrome.","volume":"1083","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025102819544982200_R24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4172\/2155-9899.1000469","article-title":"Peroxisome proliferator-activated receptor-? agonists: potential therapeutics for neuropathology associated with fetal alcohol spectrum disorders.","volume":"7","author":"Drew","year":"2016","journal-title":"J. Clin. Cell. Immunol."},{"key":"2025102819544982200_R25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisomal \u00df-oxidation pathway by a novel family of nuclear hormone receptors.","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell"},{"key":"2025102819544982200_R26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/S11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins.","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2025102819544982200_R27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/J.AJOG.2003.09.052","article-title":"Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition.","volume":"190","author":"Dunn-Albanese","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2025102819544982200_R28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/MOLEHR\/GAL057","article-title":"The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice.","volume":"12","author":"Elia","year":"2006","journal-title":"Mol. Hum. Reprod."},{"key":"2025102819544982200_R29","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/J.INTIMP.2008.09.002","article-title":"Detrimental effects of hyperandrogenism on uterine functions.","volume":"8","author":"Elia","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"2025102819544982200_R30","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/J.FERTNSTERT.2011.02.004","article-title":"Link between metformin and the peroxisome proliferator-activated receptor ? pathway in the uterine tissue of hyperandrogenized prepubertal mice.","volume":"95","author":"Elia","year":"2011","journal-title":"Fertil. Steril."},{"key":"2025102819544982200_R31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.THERIOGENOLOGY.2012.09.006","article-title":"The expression of ERa, OTR, cPLA2, COX-2, and PPAR? in the cervix of the ewe during the estrous cycle.","volume":"79","author":"Falchi","year":"2013","journal-title":"Theriogenology"},{"key":"2025102819544982200_R32","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1517\/13543784.17.8.1187","article-title":"New drugs in development for the treatment of endometriosis.","volume":"17","author":"Fedele","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2025102819544982200_R33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.","volume":"116","author":"Finck","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2025102819544982200_R34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/J.YHBEH.2007.12.013","article-title":"Neuroendocrine consequences of androgen excess in female rodents.","volume":"53","author":"Foecking","year":"2008","journal-title":"Horm. Behav."},{"key":"2025102819544982200_R35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome.","volume":"333","author":"Franks","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2025102819544982200_R36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0889-8529(03)00044-6","article-title":"Assessment and management of anovulatory infertility in polycystic ovary syndrome.","volume":"32","author":"Franks","year":"2003","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2025102819544982200_R37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1677\/JOE.1.06667","article-title":"Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.","volume":"189","author":"Froment","year":"2006","journal-title":"J. Endocrinol."},{"key":"2025102819544982200_R38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/J.BEEM.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA.","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2025102819544982200_R39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/NRENDO.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"2025102819544982200_R40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1677\/JOE.0.1820229","article-title":"Effects of peroxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.","volume":"182","author":"Gunin","year":"2004","journal-title":"J. Endocrinol."},{"key":"2025102819544982200_R41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/0974-1208.63122","article-title":"Endometrial carcinoma in a young subfertile woman with polycystic ovarian syndrome.","volume":"3","author":"Jayakrishnan","year":"2010","journal-title":"J. Hum. Reprod. Sci."},{"key":"2025102819544982200_R42","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/HUMREP\/DES042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome.","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum. Reprod."},{"key":"2025102819544982200_R43","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/J.FERTNSTERT.2012.10.017","article-title":"Prenatal hyperandrogenism and lipid profile during different age stages: an experimental study.","volume":"99","author":"Heber","year":"2013","journal-title":"Fertil. Steril."},{"key":"2025102819544982200_R44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/J.BEEM.2006.03.009","article-title":"Pregnancy complications in PCOS.","volume":"20","author":"Homburg","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2025102819544982200_R45","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/732303","article-title":"The role of peroxisome proliferator-activated receptors in the development and physiology of gametes and preimplantation embryos.","volume":"2008","author":"Huang","year":"2008","journal-title":"PPAR Res."},{"key":"2025102819544982200_R46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/J.BRAINRES.2008.04.025","article-title":"Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.","volume":"1215","author":"Hyong","year":"2008","journal-title":"Brain Res."},{"key":"2025102819544982200_R47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/347645A0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"2025102819544982200_R48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/19396368.2014.991881","article-title":"The balancing act \u2013 PPAR-?\u2019s roles at the maternal\u2013fetal interface.","volume":"61","author":"Kadam","year":"2015","journal-title":"Syst. Biol. Reprod. Med."},{"key":"2025102819544982200_R49","first-page":"532","article-title":"Estrous cycle and ovarian changes in a rat mammary carcinogenesis model after irradiation, tamoxifen chemoprevention, and aging.","volume":"53","author":"Karim","year":"2003","journal-title":"Comp. Med."},{"key":"2025102819544982200_R50","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1073\/PNAS.91.15.7355","article-title":"Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.","volume":"91","author":"Kliewer","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2025102819544982200_R51","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/471524","article-title":"Altered peroxisome-proliferator activated receptors expression in human endometrial cancer.","volume":"2012","author":"Knapp","year":"2012","journal-title":"PPAR Res."},{"key":"2025102819544982200_R52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3892\/ETM_00000040","article-title":"The use of Cox-2 and PPAR? signaling in anti-cancer therapies.","volume":"1","author":"Knopfov\u00e1","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"2025102819544982200_R53","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1210\/ENDO.142.11.8429","article-title":"Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period.","volume":"142","author":"Komar","year":"2001","journal-title":"Endocrinology"},{"key":"2025102819544982200_R54","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2174\/092986706778201666","article-title":"In utero exposure to phthalates and fetal development.","volume":"13","author":"Latini","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"2025102819544982200_R55","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/J.FERTNSTERT.2004.02.148","article-title":"Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis.","volume":"82","author":"Lebovic","year":"2004","journal-title":"Fertil. Steril."},{"key":"2025102819544982200_R56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1043-2760(00)00243-5","article-title":"PPARd functions as a prostacyclin receptor in blastocyst implantation.","volume":"11","author":"Lim","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"2025102819544982200_R57","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1101\/GAD.13.12.1561","article-title":"Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.","volume":"13","author":"Lim","year":"1999","journal-title":"Genes Dev."},{"key":"2025102819544982200_R58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.JRI.2004.04.002","article-title":"Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function.","volume":"64","author":"Luchetti","year":"2004","journal-title":"J. Reprod. Immunol."},{"key":"2025102819544982200_R59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/J.DOMANIEND.2005.07.003","article-title":"Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production.","volume":"30","author":"MacLaren","year":"2006","journal-title":"Domest. Anim. Endocrinol."},{"key":"2025102819544982200_R60","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1210\/EN.2005-1338","article-title":"Fetal programming: prenatal testosterone treatment leads to follicular persistence\/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment.","volume":"147","author":"Manikkam","year":"2006","journal-title":"Endocrinology"},{"key":"2025102819544982200_R61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/J.MRFMMM.2009.09.009","article-title":"Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.","volume":"690","author":"Martin","year":"2010","journal-title":"Mutat. Res."},{"key":"2025102819544982200_R62","doi-asserted-by":"publisher","first-page":"8328","DOI":"10.1074\/JBC.274.12.8328","article-title":"Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells.","volume":"274","author":"Meade","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2025102819544982200_R63","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/MOLEHR\/5.11.1011","article-title":"The involvement of nitric oxide in corpus luteum regression in the rat: feedback mechanism between prostaglandin F(2alpha) and nitric oxide.","volume":"5","author":"Motta","year":"1999","journal-title":"Mol. Hum. Reprod."},{"key":"2025102819544982200_R64","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/614852","article-title":"Regulation of cell proliferation and differentiation by PPAR\u00df\/d.","volume":"2008","author":"M\u00fcller","year":"2008","journal-title":"PPAR Res."},{"key":"2025102819544982200_R65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/S00441-011-1208-4","article-title":"Expression of peroxisome proliferator-activated receptor isoforms in the rat uterus during early pregnancy.","volume":"345","author":"Nishimura","year":"2011","journal-title":"Cell Tissue Res."},{"key":"2025102819544982200_R66","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1210\/EN.2014-1266","article-title":"Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep.","volume":"155","author":"Padmanabhan","year":"2014","journal-title":"Endocrinology"},{"key":"2025102819544982200_R67","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/HUMUPD\/DMV029","article-title":"Pregnancy complications in women with polycystic ovary syndrome.","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"2025102819544982200_R68","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2174\/1381612822666160216151852","article-title":"Oxidative stress in polycystic ovary syndrome.","volume":"22","author":"Papalou","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"2025102819544982200_R69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/J.STEROIDS.2017.08.007","article-title":"Endometrium and steroids, a pathologic overview.","volume":"126","author":"Plaza-Parrochia","year":"2017","journal-title":"Steroids"},{"key":"2025102819544982200_R70","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"key":"2025102819544982200_R71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.THERIOGENOLOGY.2014.02.016","article-title":"Rosiglitazone stimulates peroxisome proliferator-activated receptor gamma expression and directly affects in vitro steroidogenesis in porcine ovarian follicles.","volume":"82","author":"Rak-Mardyla","year":"2014","journal-title":"Theriogenology"},{"key":"2025102819544982200_R72","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1177\/1933719111430993","article-title":"Endometrial abnormality in women with polycystic ovary syndrome.","volume":"19","author":"Shang","year":"2012","journal-title":"Reprod. Sci."},{"key":"2025102819544982200_R73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1756-9966-33-41","article-title":"Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.","volume":"33","author":"Shao","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2025102819544982200_R74","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/J.FERTNSTERT.2010.09.008","article-title":"In vitro effects of peroxisome proliferator-activated receptor-? ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells.","volume":"95","author":"Sharma","year":"2011","journal-title":"Fertil. Steril."},{"key":"2025102819544982200_R75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3121\/CMR.2.1.13","article-title":"Polycystic ovarian syndrome: diagnosis and management.","volume":"2","author":"Sheehan","year":"2004","journal-title":"Clin. Med. Res."},{"key":"2025102819544982200_R76","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1042\/BJ20070089","article-title":"Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus.","volume":"406","author":"Sheldrick","year":"2007","journal-title":"Biochem. J."},{"key":"2025102819544982200_R77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/J.MCE.2017.09.022","article-title":"Androgens and endometrium: new insights and new targets.","volume":"465","author":"Simitsidellis","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"2025102819544982200_R78","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1210\/JC.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025102819544982200_R79","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/215158","article-title":"The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.","volume":"2010","author":"Sobolewski","year":"2010","journal-title":"Int. J. Cell Biol."},{"key":"2025102819544982200_R80","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/J.THERIOGENOLOGY.2017.06.008","article-title":"PPAR expression throughout the oestrous cycle in the bovine endometrium.","volume":"100","author":"Socha","year":"2017","journal-title":"Theriogenology"},{"key":"2025102819544982200_R81","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/J.1600-0897.2007.00514.X","article-title":"Peroxisome proliferator-activated receptors: new players in the field of reproduction.","volume":"58","author":"Toth","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"key":"2025102819544982200_R82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/J.JPAG.2014.05.003","article-title":"Infertility and the presence of insulin resistance are associated with increased oxidative stress in young, non-obese Turkish women with polycystic ovary syndrome.","volume":"28","author":"Turan","year":"2015","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"2025102819544982200_R83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/J.1471-4159.2006.04376.X","article-title":"Peroxisome proliferator-activated receptor-? agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents: peroxisome proliferator-activated receptor-? agonists induce neuroprotection.","volume":"101","author":"Tureyen","year":"2007","journal-title":"J. Neurochem."},{"key":"2025102819544982200_R84","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases.","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"2025102819544982200_R85","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.2174\/1381612811319250010","article-title":"The biology of the peroxisome proliferator-activated receptor system in the female reproductive tract.","volume":"19","author":"V\u00e9lez","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"2025102819544982200_R86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/J.PHAREP.2018.09.009","article-title":"Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats.","volume":"71","author":"Velez","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"2025102819544982200_R87","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/J.YGYNO.2009.06.033","article-title":"Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.","volume":"115","author":"Villavicencio","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"2025102819544982200_R88","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4612306","article-title":"Peroxisome proliferator-activated receptors in female reproduction and fertility.","volume":"2016","author":"Vitti","year":"2016","journal-title":"PPAR Res."},{"key":"2025102819544982200_R89","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/J.BEEM.2018.03.008","article-title":"Evidence from animal models on the pathogenesis of PCOS.","volume":"32","author":"Walters","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2025102819544982200_R90","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0018-506X(03)00061-8","article-title":"Fetal testosterone surge: specific modulations induced in male rats by maternal stress and\/or alcohol consumption.","volume":"43","author":"Ward","year":"2003","journal-title":"Horm. Behav."},{"key":"2025102819544982200_R91","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1210\/ENDO-127-6-3196","article-title":"Inhibin and activin locally regulate rat ovarian folliculogenesis.","volume":"127","author":"Woodruff","year":"1990","journal-title":"Endocrinology"},{"key":"2025102819544982200_R92","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/723243","article-title":"PPARs and female reproduction: evidence from genetically manipulated mice.","volume":"2008","author":"Yang","year":"2008","journal-title":"PPAR Res."},{"key":"2025102819544982200_R93","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1210\/EN.2006-0067","article-title":"Peroxisome proliferator-activated receptor a deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: modulation of T cell differentiation.","volume":"147","author":"Yessoufou","year":"2006","journal-title":"Endocrinology"},{"key":"2025102819544982200_R94","doi-asserted-by":"publisher","first-page":"13600","DOI":"10.1074\/JBC.M409468200","article-title":"The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.","volume":"280","author":"Yu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2025102819544982200_R95","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/J.MRFMMM.2011.02.015","article-title":"Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis.","volume":"711","author":"Ziech","year":"2011","journal-title":"Mutat. Res."},{"key":"2025102819544982200_R96","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8589318","article-title":"Roles of oxidative stress in polycystic ovary syndrome and cancers.","volume":"2016","author":"Zuo","year":"2016","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Reproduction, Fertility and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/rd\/article-pdf\/31\/8\/1401\/313428\/rd18432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/rd\/article-pdf\/31\/8\/1401\/313428\/rd18432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:54:52Z","timestamp":1761695692000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/rd\/article\/31\/8\/1401\/50287\/Prenatal-androgen-excess-alters-the-uterine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":96,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,7,10]]}},"URL":"https:\/\/doi.org\/10.1071\/rd18432","relation":{},"ISSN":["1031-3613","1448-5990"],"issn-type":[{"type":"print","value":"1031-3613"},{"type":"electronic","value":"1448-5990"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}